E

ELVN

Enliven Therapeutics Inc

45.84

-0.67-1.44%
Pre Market: 46.20  +0.36  +0.79%04:19 10/01 EDT
1D
5D
Daily
Weekly
Monthly
Quarterly
Yearly
OPEN/PREV CLOSE40.90/41.36
TODAY RANGE39.91-40.90
VOL359.06K
MARKET CAP2.95B
52 WEEK RANGE14.79-62.32
AVG VOL (3M)1.12M
% TURNOVER0.49%
TURNOVER--
P/E (TTM)-24.1127
% RANGE2.39%
EPS(TTM)-1.6680
P/E(FORWARD)-20.6582
P/B3.291
BVPS12.22
DIVIDEND--
P/S--
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP2.48B
SHARES OUTSTANDING73.27M
NEXT EARNINGS11/10-11/16
FREE FLOAT61.73M
LOT SIZE1
EX-DATE02/24/2023
Same Industry
Name/Symbol
Change%
Price

E

Enliven Therapeutics Inc

ELVN

-1.44%
45.84

R

Regeneron Pharmaceuticals

REGN

-0.26%
801.82

G

GridAI Tech

GRDX

-9.97%
3.430

B

BIONTECH

BNTX

-0.37%
98.09

U

United Therapeutics Corp.

UTHR

-3.52%
472.21

V

Vertex Pharmaceuticals Inc

VRTX

-1.55%
508.34

S

Siga Technologie

SIGA

+6.15%
3.450

M

Moderna

MRNA

-2.55%
154.04

C

Charles Riv Labs Intl Inc

CRL

-1.28%
278.06

MEDP

--

T

Talphera Inc

TLPH

-0.85%
1.160

C

China Biologic

CBPO

0.00%
119.99

I

ICON plc

ICLR

-2.53%
171.13

I

Iqvia Hldgs Inc

IQV

-1.12%
266.42

M

MOLECULAR PARTNERS AG

MOLN

0.00%
3.910

A

Arcturus Therape

ARCT

-2.11%
14.38

G

Gilead Sciences Inc

GILD

-0.52%
150.11

PRAH

--

I

Incyte Corp

INCY

-1.50%
121.35

A

Aptevo Therapeutics Inc

APVO

+2.51%
1.840

BSTC

--